HSBC Holdings’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

HSBC Holdings’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26,256	Closed	-$413K	–	3222
2024 Q1	$413K	Sell	26,256 -3,414	-12%	-$52.5K	﹤0.01%	2199
2023 Q4	$482K	Buy	29,670 +11,057	+59%	+$141K	﹤0.01%	2064
2023 Q3	$237K	Sell	18,613 -118,997	-86%	-$1.64M	﹤0.01%	2340
2023 Q2	$1.94M	Buy	+137,610	New	+$1.97M	﹤0.01%	1449
2022 Q2	–	Sell	-11,730	Closed	-$110K	–	3506
2022 Q1	$110K	Buy	11,730 +476	+4%	+$4.05K	﹤0.01%	3107
2021 Q4	$115K	Buy	+11,254	New	+$212K	﹤0.01%	3122
2021 Q1	–	Sell	-7,258	Closed	-$420K	–	3209
2020 Q4	$420K	Buy	+7,258	New	+$430K	﹤0.01%	2315
2019 Q4	–	Sell	-9,719	Closed	-$330K	–	3227
2019 Q3	$330K	Buy	+9,719	New	+$288K	﹤0.01%	2571

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

HSBC Holdings's DCPH Position: Q2 2024 in Review

HSBC Holdings sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 26,256 shares — an estimated $413K sold.

HSBC Holdings first reported a position in DCPH in Q3 2019 and held it in 8 quarters. The position peaked at $1.94M in Q2 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

HSBC Holdings reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
HSBC Holdings sold 26,256 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $413K.
HSBC Holdings first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 8 quarters.
HSBC Holdings's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.94M in Q2 2023.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on HSBC Holdings's 13F filing for Q2 2024, filed 12 Aug 2024.